ATE276736T1 - Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion - Google Patents

Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion

Info

Publication number
ATE276736T1
ATE276736T1 AT00921641T AT00921641T ATE276736T1 AT E276736 T1 ATE276736 T1 AT E276736T1 AT 00921641 T AT00921641 T AT 00921641T AT 00921641 T AT00921641 T AT 00921641T AT E276736 T1 ATE276736 T1 AT E276736T1
Authority
AT
Austria
Prior art keywords
skin
lipid barrier
barrier function
prevention
treatment
Prior art date
Application number
AT00921641T
Other languages
English (en)
Inventor
Daniel H Maes
Jon Anderson
Kenneth D Marenus
Thomas Mammone
Christina G Fthenakis
Original Assignee
Color Access Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Color Access Inc filed Critical Color Access Inc
Application granted granted Critical
Publication of ATE276736T1 publication Critical patent/ATE276736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00921641T 2000-04-04 2000-04-04 Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion ATE276736T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/008871 WO2001074327A1 (en) 2000-04-04 2000-04-04 Composition for improving skin lipid barrier function

Publications (1)

Publication Number Publication Date
ATE276736T1 true ATE276736T1 (de) 2004-10-15

Family

ID=21741232

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00921641T ATE276736T1 (de) 2000-04-04 2000-04-04 Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion

Country Status (13)

Country Link
US (2) US20080213202A1 (de)
EP (1) EP1272154B1 (de)
JP (1) JP2003528904A (de)
KR (1) KR100596595B1 (de)
AT (1) ATE276736T1 (de)
AU (1) AU782378B2 (de)
CA (1) CA2374763C (de)
DE (1) DE60014180T2 (de)
DK (1) DK1272154T3 (de)
ES (1) ES2225123T3 (de)
HK (1) HK1056821B (de)
PT (1) PT1272154E (de)
WO (1) WO2001074327A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1027045A4 (de) 1997-10-31 2004-12-08 Arch Dev Corp Methoden und zusammenstellungen zur regelierung des s-alpha-reduktaseaktivität
US6696484B2 (en) 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
JP2001316221A (ja) * 2000-05-10 2001-11-13 Naris Cosmetics Co Ltd 抗老化剤および化粧料
DE10048596A1 (de) * 2000-09-30 2002-04-25 Henkel Kgaa Entzündungshemmende Wirkstoffe
WO2002080880A2 (en) * 2002-05-02 2002-10-17 Priscilla S.R.L. Unipersonale Anti-stretch mark preparation and method thereof
FR2850573B1 (fr) * 2003-02-03 2006-07-07 Oreal Utilisation de l'acide 3-0-acetyl 11-ceto-boswellique ou d'un extrait vegetal en contenant, pour reduire les rides d'expression
PL209905B1 (pl) * 2004-01-15 2011-11-30 Bringwell Internat Ab Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego
CN1946368B (zh) 2004-04-30 2012-05-09 花王株式会社 皱纹改善剂及皮肤化妆品
GB0413954D0 (en) * 2004-06-22 2004-07-28 Altunkaya Ali Compositions for topical treatment
ES2511490T3 (es) * 2004-07-01 2014-10-22 E-L Management Corp. Composiciones cosméticas y procedimientos que contienen un agente de bronceado y ácido ursólico encapsulado en liposoma
KR100871962B1 (ko) * 2004-07-01 2008-12-08 이-엘 매니지먼트 코포레이션 태닝제와 리포좀 캡슐화된 우르솔릭 애시드를 함유하는화장용 조성물 및 방법
WO2006040349A1 (en) * 2004-10-14 2006-04-20 Symrise Gmbh & Co. Kg Process for strengthening the barrier function of undamaged skin
JP4938302B2 (ja) * 2005-12-12 2012-05-23 ポーラ化成工業株式会社 皮膚バリア機能向上のための皮膚外用剤
FI121468B (fi) * 2006-06-07 2010-11-30 Valtion Teknillinen Betuliiniperäiset yhdisteet antimikrobisina aineina
EP2014276A1 (de) * 2007-06-20 2009-01-14 Cognis IP Management GmbH Kosmetische Zusammensetzungen mit Sclareolid- und Hesperidin-Methyl-Chalcon
FR2930445B1 (fr) * 2008-04-29 2012-06-08 Am Phyto Conseil Utilisation d'une composition contenant le 7-dehydrocholesterol ou un extrait naturel de micro-organisme ou vegetal ou animal
FR2932086A1 (fr) * 2008-06-06 2009-12-11 Lvmh Rech Methode de soin cosmetique anti-age par stimulation de l'expression de la survivine
FR2942962B1 (fr) * 2009-03-11 2011-04-22 Oreal Utilisation d'une dihydrochalcone ou l'un de ses derives pour ameliorer l'etat de surface d'une peau fragilisee et/ou alteree
US20100303745A1 (en) * 2009-05-29 2010-12-02 Brownberry Skin bronzer
US8435541B2 (en) * 2010-09-02 2013-05-07 Bath & Body Works Brand Management, Inc. Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities
SE1150819A1 (sv) 2011-09-12 2013-03-13 Stora Enso Oyj Förfarande för derivatisering av en kemisk komponent i trä
SE536995C2 (sv) 2011-09-12 2014-11-25 Stora Enso Oyj Förfarande för derivatisering av en kemisk komponent i trä
EP2789369B1 (de) * 2013-04-14 2018-06-06 Symrise AG Eine Zubereitung zur Aufhellung von Haut und Haaren
US9289374B2 (en) * 2014-04-23 2016-03-22 Lifevantage Corporation Topical compositions and methods for reducing oxidative stress
EP3097905B1 (de) * 2015-05-28 2020-11-04 Symrise AG Kosmetische zubereitungen
US10137073B2 (en) 2016-01-02 2018-11-27 L'oreal Cosmetic compositions comprising ceramides and cholesterol
CN109562046A (zh) 2016-05-30 2019-04-02 西姆莱斯股份公司 含有香紫苏内酯的化妆品组合物
US11071701B2 (en) 2016-06-30 2021-07-27 Symrise Ag Medicament and cosmetic composition comprising resorcinol derivatives
JPWO2020179457A1 (de) * 2019-03-04 2020-09-10
EP3981378A1 (de) 2020-10-09 2022-04-13 Evonik Operations GmbH Zusammensetzungen enthaltend ceramid, polyglycerincarbonsäureester und cholesterol
EP4486314A1 (de) * 2022-03-01 2025-01-08 ISP Investments LLC Sclareol oder sclareolid zur verbesserung der kopfhauterkrankungen und des haarwachstums
CN116172934A (zh) * 2022-11-30 2023-05-30 湖北省吉美化妆品有限公司 兼具皮肤屏障修复功能和补水功能的组合物及其应用
WO2024192254A1 (en) * 2023-03-15 2024-09-19 Balmere Skin, Inc. Compositions for treatment of skin

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161911A (ja) 1984-01-31 1985-08-23 Kanebo Ltd 皮膚化粧料
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
US4992477A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Skin moisturizing composition and method of preparing same
US5084270A (en) * 1988-04-22 1992-01-28 Revlon, Inc. Cosmetic compositions containing N-alkoxyalkylamides
US5508034A (en) 1988-08-12 1996-04-16 Genderm Corporation Method and composition for treating and preventing dry skin disorders
WO1990001323A1 (en) 1988-08-12 1990-02-22 Bernstein Joel E Method and composition for treating and preventing dry skin disorders
AU5195090A (en) 1989-03-07 1990-10-09 Plough Inc. Liposome compositions
JPH0551314A (ja) 1991-08-20 1993-03-02 Kanebo Ltd 皮膚化粧料
JP2567317B2 (ja) 1991-11-14 1996-12-25 花王株式会社 毛髪化粧料
JPH05310526A (ja) * 1992-05-07 1993-11-22 Eisai Co Ltd 細胞分化促進剤
ES2145052T3 (es) 1992-06-19 2000-07-01 Univ California Lipidos para la humidificacion epidermica y la reparacion de la funcion de barrera.
FR2694289B1 (fr) * 1992-07-29 1994-10-14 Oreal Composés amphiphiles soufrés, fluorés et polyglycérolés, composition cosmétique ou pharmaceutique en comportant, procédé de préparation et vésicules formées.
US5310759A (en) * 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
US5885565A (en) 1993-03-19 1999-03-23 Cellegy Pharmaceuticals Inc. Methods for inducing phase separation of epithelial lipid bilayers
CA2097997C (en) 1993-06-08 2006-01-10 Jose P. Sestelo Vitamin d compounds and method of preparing these compounds
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
US5589194A (en) * 1993-09-20 1996-12-31 Minnesota Mining And Manufacturing Company Method of encapsulation and microcapsules produced thereby
FR2714829B1 (fr) * 1994-01-10 1996-02-02 Oreal Composition cosmétique et/ou dermatologique pour le traitement du vieillissement contenant des céramides, son utilisation.
CA2181699A1 (en) * 1994-01-19 1995-07-27 Takako Fujii Dermatologic composition
FR2716622B1 (fr) * 1994-02-28 1996-04-12 Oreal Compositions cosmétiques autobronzantes à base de dihydroxyacétone, procédé de préparation et utilisation.
FR2717389B1 (fr) * 1994-03-18 1996-06-07 Lvmh Rech Utilisation du ginsénoside Ro ou d'un extrait végétal en contenant pour stimuler la synthèse du collagène.
IT1270602B (it) * 1994-07-12 1997-05-07 Indena Spa Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
FR2727626B1 (fr) * 1994-12-05 1997-01-17 Oreal Compositions cosmetiques autobronzantes a base de dihydroxyacetone, d'alkylpolyosides et d'alcools gras
US5529769A (en) * 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
GB9500024D0 (en) * 1995-01-04 1995-03-01 Sod Conseils Rech Applic Treatment of excessive cell proliferation disorders
US6004568A (en) 1995-02-17 1999-12-21 Lvmh Recherche Cosmetic or pharmaceutical, particularly dermatological, composition containing a Bertholletia extract
FR2752527B1 (fr) * 1996-08-22 1998-11-13 Lvmh Rech Utilisation d'un extrait de bertholletia dans le domaine cosmetique ou pharmaceutique, notamment dermatologique, et pour la preparation de milieux de culture de cellules
US5658947A (en) 1995-03-21 1997-08-19 Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma using betalinic acid
FR2732680B1 (fr) 1995-04-05 1997-05-09 Oreal Composes de type ceramides, leur procede de preparation et leur utilisation
US5738856A (en) * 1995-11-03 1998-04-14 Ocular Research Of Boston, Inc. Skin care preparation and method
PT892638E (pt) * 1996-04-04 2003-03-31 Cilag Ag Formulacao topica de vitamina d a base de lipossomas
JP3426436B2 (ja) * 1996-05-28 2003-07-14 カネボウ株式会社 皮膚化粧料
US5705145A (en) * 1996-08-21 1998-01-06 E-L Management Corp. Skin tanning compositions and method
DE19644637C1 (de) * 1996-10-17 1998-08-13 Lancaster Group Ag Kosmetisches Hautbräunungs- und Lichtschutzmittel
DE19642872C1 (de) 1996-10-17 1998-02-12 Henkel Kgaa Verwendung von Sterolsulfaten als Wirkstoffe in kosmetischen und/oder pharmazeutischen Mitteln zur Inhibierung von Serinproteasen
FR2755368B1 (fr) 1996-11-04 1999-03-19 Oreal Composition rincable pour le soin de la peau
FR2779059B1 (fr) * 1998-05-29 2004-09-10 Guerlain Procede de traitement cosmetique pour lutter contre les effets du vieillissement cutane; nouvelles compositions cosmetiques pour sa mise en oeuvre
FR2757055B1 (fr) 1996-12-17 1999-02-05 Oreal Compositions comprenant un derive de dibenzoylmethane, un derive de 1,2,3-triazine et un benzalmalonate de dialkyle et utilisations
FR2761601A1 (fr) * 1997-04-04 1998-10-09 Oreal Compositions cosmetiques autobronzantes
JPH115742A (ja) 1997-04-21 1999-01-12 Shiseido Co Ltd コレステロール硫酸含有外用剤
FR2763852B1 (fr) 1997-05-28 1999-07-09 Oreal Composition comprenant un derive de l'acide cinnamique et un polymere polyamine
JPH1129467A (ja) * 1997-07-09 1999-02-02 Shiseido Co Ltd プロテアーゼ阻害剤
JPH1129468A (ja) * 1997-07-09 1999-02-02 Shiseido Co Ltd プロテアーゼ阻害剤
FR2770776B1 (fr) * 1997-11-07 2000-03-17 Lvmh Rech Utilisations du d-xylose et de ses esters pour ameliorer la fonctionnalite des cellules de l'epiderme
JPH11171758A (ja) * 1997-12-12 1999-06-29 Maruzen Seiyaku Kk エラスターゼ阻害剤および皮膚外用剤
AU735384B2 (en) * 1998-03-16 2001-07-05 Procter & Gamble Company, The Compositions for regulating skin appearance
JPH11292777A (ja) * 1998-04-08 1999-10-26 Lion Corp フォルスコリン含有抽出物及びその抽出物を含有する組成物
DE19824727A1 (de) 1998-06-03 1999-12-09 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Catechinen oder einem Gehalt an Extrakt von grünem Tee
US6150381A (en) 1998-06-09 2000-11-21 R.J. Reynolds Tobacco Company Methods of treating microbial infection and therapeutic formulations therefor
FR2781670B1 (fr) * 1998-07-30 2001-09-07 Oreal Patch cosmetique ou pharmaceutique et son conditionnement
DE19834812A1 (de) 1998-08-01 2000-02-03 Beiersdorf Ag Verwendung von Sterolderivaten in kosmetischen und dermatologischen Zubereitungen zur Stärkung der Barrierefunktion der Haut
US20020098207A1 (en) 1999-02-08 2002-07-25 Daniel H. Maes Cholesterol sulfate compositions for enhancement of stratum corneum function

Also Published As

Publication number Publication date
HK1056821A1 (en) 2004-03-05
DE60014180D1 (de) 2004-10-28
DK1272154T3 (da) 2005-01-31
WO2001074327A1 (en) 2001-10-11
CA2374763C (en) 2008-09-30
US8710034B2 (en) 2014-04-29
JP2003528904A (ja) 2003-09-30
ES2225123T3 (es) 2005-03-16
US20130095046A1 (en) 2013-04-18
CA2374763A1 (en) 2001-10-11
DE60014180T2 (de) 2005-10-06
HK1056821B (en) 2005-03-18
AU782378B2 (en) 2005-07-21
PT1272154E (pt) 2004-11-30
AU4193100A (en) 2001-10-15
US20080213202A1 (en) 2008-09-04
KR20020040670A (ko) 2002-05-30
EP1272154A1 (de) 2003-01-08
KR100596595B1 (ko) 2006-07-06
EP1272154B1 (de) 2004-09-22

Similar Documents

Publication Publication Date Title
ATE276736T1 (de) Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion
ATE363271T1 (de) Verfahren zur verbesserung der grösse und des aussehens einer wunde
BR9908275A (pt) Inibidores de enzimas fosfolipase
EP1401421A4 (de) Verfahren zur behandlung von nagelpilz und anderen mikrobiellen und mykotischen erkrankungen und dafür geeignete zusammensetzungen
MXPA01006917A (es) Composicion topica que comprende n-acetilaldosaminas o acidos n-acetilaminos.
DE69818049D1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
DE60328909D1 (de) Zusammensetzung zur behandlung von ichthyosis unter verwendung von antitrypsin
WO2004047735A3 (en) Broad spectrum anti-viral therapeutics and prophylaxis
DE69627988D1 (de) Inhibitoren der no-synthase
IT1288290B1 (it) Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
DE50207442D1 (de) Behandlung der akne mit lipoxygenase inhibitoren
TW200509983A (en) The dermal external agent for inhibiting or repairing the dermal damage due to drying
EA200200058A1 (ru) Пиримидин-2,4,6-трионовые ингибиторы металлопротеиназ
WO2002009637A3 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
SE0002202D0 (sv) New peptides
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
ATE318606T1 (de) Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
WO2001034172A3 (en) Methods and compositions for treating reward deficiency syndrome
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
BR0313278A (pt) Compostos, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo e sua utilização, método para o tratamento e profilaxia de enfermidades e obesidade e utilização dos compostos
CR20230314A (es) N-(2-(4-cianotiazolidin-3-il)-2-oxoetil)-quinolin-4-carboxamidas
ATE131066T1 (de) Mittel zur hemmung von hiv-proteasen.
SE0301883D0 (sv) New use II
SE0301884D0 (sv) New use III

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1272154

Country of ref document: EP

REN Ceased due to non-payment of the annual fee